Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 301 AL 315

A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease

D'Onofrio G, Sancarlo D, Addante F, Ciccone F, Cascavilla L, Paris F, Elia AC, Nuzzaci C, Picoco M, Greco A, Panza F, Pilotto A.

Int J Geriatr Psychiatry. 2015 Sep;30(9):965-75. doi: 10.1002/gps.4247. Epub 2014 Dec 12.

A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD)

Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker Z; MAIN-AD investigators.

J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15.

Targeting microglia for the treatment of Alzheimer's disease

McGeer PL, McGeer EG.

Expert Opin Ther Targets. 2015 Apr;19(4):497-506. doi: 10.1517/14728222.2014.988707. Epub 2014 Nov 29.

French Validation of the Revised Algase Wandering Scale for Long-Term Care

Martin E, Biessy-Dalbe N, Albaret JM, Algase DL.

Am J Alzheimers Dis Other Demen. 2015 Dec;30(8):762-7. doi: 10.1177/1533317513494454. Epub 2013 Jul 2.

Evidence-Based Program Replication: Translational Activities, Experiences, and Challenges

Primetica B, Menne HL, Bollin S, Teri L, Molea M.

J Appl Gerontol. 2015 Aug;34(5):652-70. doi: 10.1177/0733464813508888. Epub 2013 Nov 11.

The Impact of the REACH II Intervention on Caregivers' Perceived Health

Basu R, Hochhalter AK, Stevens AB.

J Appl Gerontol. 2015 Aug;34(5):590-608. doi: 10.1177/0733464813499640. Epub 2013 Sep 9.

Cognitive rehabilitation in a visual variant of Alzheimer's disease

Alves J, Magalhães R, Arantes M, Cruz S, Gonçalves ÓF, Sampaio A.

Appl Neuropsychol Adult. 2015;22(1):73-8. doi: 10.1080/23279095.2013.831865. Epub 2013 Dec 9.

Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: evidence on efficacy and neurobiological correlations

García-Alberca JM.

Neurologia. 2015 Jan-Feb;30(1):8-15. doi: 10.1016/j.nrl.2012.10.002. Epub 2012 Dec 15.

The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders

Berman DE, Ringe D, Petsko GA, Small SA.

Neurotherapeutics. 2015 Jan;12(1):12-8. doi: 10.1007/s13311-014-0321-y.

Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis

Viola KL, Klein WL.

Acta Neuropathol. 2015 Feb;129(2):183-206. doi: 10.1007/s00401-015-1386-3. Epub 2015 Jan 22.

Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry

Gaspar A, Milhazes N, Santana L, Uriarte E, Borges F, Matos MJ.

Curr Top Med Chem. 2015;15(5):432-45.

Is lithium a neuroprotective agent?

Vo TM, Perry P, Ellerby M, Bohnert K.

Ann Clin Psychiatry. 2015 Feb;27(1):49-54.

From Neurodegeneration to Brain Health: An Integrated Approach

Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz WK, Wang Y, Whitehouse P, Lerner A.

J Alzheimers Dis. 2015;46(1):271-83. doi: 10.3233/JAD-150043.

[New therapeutic approaches]

Kurz A, Grimmer T.

Ther Umsch. 2015 Apr;72(4):279-85. doi: 10.1024/0040-5930/a000676.

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases

Montine TJ, Montine KS.

J Exp Med. 2015 May 4;212(5):601-5. doi: 10.1084/jem.20150656.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias